HIGH RISK FOR UNRELATED MORTALITY AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY FOR BARRETT’S NEOPLASIA IN A NATIONWIDE COHORT OF 1154 PATIENTS

Eva Verheij  ¹     Sanne van Munster  ¹     Esther Toes-Zoutendijk  ²     Iris Lansdorp-Vogelaar  ³     Esther A. Nieuwenhuis  ³     Cary Cotton  ⁴     Bas L.A.M. Weusten  ⁵     Lorenza Alvarez Herrero  ⁵     Alaa Alkhalaf  ⁶     Boudewijn Edwin Schenk  ⁶     Erik J. Schoon  ⁷     Wouter L. Curvers  ⁷     Arjun D. Koch  ⁸     Pieter Jan de Jonge  ⁸     Thjon J. Tang  ⁹     Wouter B. Nagengast  ¹⁰     Jessie Westerhof  ¹⁰     Martin Houben  ¹¹     Nicolas Shaheen  ¹¹     Jacques J. Bergman  ¹¹     Roos E. Pouw  ^12    
1 Amsterdam UMC location University of Amsterdam, Amsterdam, Netherlands
² University Medical Center Rotterdam, Rotterdam, Netherlands
³ Erasmus MC, Rotterdam, Netherlands
⁴ University of North Carolina School of Medicine, Chapel Hill, United States
⁵ St Antonius Hospital, Nieuwegein, Netherlands
⁶ Isala Hospital, Zwolle, Netherlands
⁷ Catharina Hospital, Eindhoven, Netherlands
⁸ Erasmus MC - University Medical Center, Rotterdam, Netherlands
⁹ IJsselland Hospital, Capelle aan den IJssel, Netherlands
¹⁰ UMC Groningen, Groningen, Netherlands
¹¹ HagaTeaching Hospital, Den Haag, Netherlands
¹² Amsterdam UMC location Vrije Universiteit Amsterdam, Amsterdam, Netherlands

Topic
Digestive Oncology, Endoscopy, Oesophagus

Session
Endoscopic treatment of Barrett's and oesophageal neoplasia

Conference
UEG Week 2022

Citation
United European Gastroenterology Journal 2022; 10 (Supplement 8)